NIH-funded research Sbir 2 grant

Developing a device for quick blood tests at home

Official title: Whole Blood Point of Care Metabolic Measurement

Funded at Sequitur Health Corp. · NIH-10691330 · Data updated 2026-11-12

This study is working on a new, easy-to-use device that can quickly check for important health markers in your blood right at home, which could really help people with rare metabolic disorders and even newborns.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionSequitur Health Corp.
NIH-funded
Lab location1 site (Scottsdale, United States)
Project startSeptember 17, 2021
Project endAugust 31, 2025
Funding year2023
Award (this year)$703,162
NIH project number5R44HD107897-03
Project IDNIH-10691330 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with rare metabolic disorders and newborns who are being screened for these conditions.

Less likely to help

Patients with common metabolic disorders or those who do not have metabolic conditions may not benefit from this research.

What this research studies

This research focuses on creating a new point of care technology that allows for the direct measurement of specific biomarkers in whole blood without the need for complex laboratory processes. By utilizing advanced sensor materials, the device aims to provide accurate and immediate results, which can significantly enhance the management of rare metabolic disorders. The project will also work towards obtaining FDA clearance for this innovative device, making it accessible for both at-home use and newborn screening.

Why it matters

Potential benefit: If successful, this research could enable faster and more accurate monitoring of metabolic disorders, improving patient outcomes and management.

How similar studies have gone: Similar approaches in point of care testing have shown promise in improving patient management and outcomes, indicating potential success for this novel device.

Where this research is happening

  • Sequitur Health Corp.
    Scottsdale, United States
    Active

Researchers

  • Principal investigator: Thomas, Marylaura Lind — Sequitur Health Corp.
  • Study coordinator: Thomas, Marylaura Lind

Related research

Other NIH-funded projects on the same topics.

  • Home blood metabolite monitor for at-home health management

    A home device to reliably measure a specific blood metabolite that can trigger metabolic crises, helping patients, caregivers, and doctors manage health from home.

    NIH research Sequitur Health Corp. · Scottsdale, United States · NIH-11415774

  • Home blood test for monitoring harmful metabolic levels

    A small, at‑home device that measures a dangerous blood metabolite from one drop for people with metabolic disorders.

    NIH research Sequitur Health Corp. · Scottsdale, United States · NIH-11193960

  • Home monitoring for dangerous metabolic buildups

    A small at-home device that lets people with certain metabolic conditions check a key blood chemical each morning to catch rising levels before a crisis.

    NIH research Sequitur Health Corp. · Scottsdale, United States · NIH-11182502

  • Developing a home device to measure blood metabolites for metabolic disorders

    This study is working on a handy device that lets people with certain metabolic disorders check important substances in their blood right at home, making it easier to catch problems early and stay healthy.

    NIH research Sequitur Health Corp. · Scottsdale, United States · NIH-11008473

  • Monitoring metabolic disorders at home

    This study is testing a new home device that helps people with metabolic disorders check their blood levels easily, so they can catch any problems early and stay in touch with their doctors for better health.

    NIH research Sequitur Health Corp. · Scottsdale, United States · NIH-10934523

  • A new device for measuring blood biomarkers at home

    This study is working on a new device that can quickly and easily check for important health markers in whole blood, which could really help babies and people with rare metabolic disorders get the care they need right at home or in a doctor's office.

    NIH research Sequitur Health Corp. · Scottsdale, United States · NIH-10909646

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.